Free Trial

Prestige Consumer Healthcare (PBH) Stock Forecast & Price Target

$71.57
-0.24 (-0.33%)
(As of 07/18/2024 ET)

Prestige Consumer Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 4 Wall Street analysts who have issued ratings for Prestige Consumer Healthcare in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for PBH.

Consensus Price Target

$98.25
37.28% Upside
High Forecast$117.00
Average Forecast$98.25
Low Forecast$80.00

According to the 4 analysts' twelve-month price targets for Prestige Consumer Healthcare, the average price target is $98.25. The highest price target for PBH is $117.00, while the lowest price target for PBH is $80.00. The average price target represents a forecasted upside of 37.28% from the current price of $71.57.

TypeCurrent Forecast
7/19/23 to 7/18/24
1 Month Ago
6/19/23 to 6/18/24
3 Months Ago
4/20/23 to 4/19/24
1 Year Ago
7/19/22 to 7/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$98.25$91.25$110.00$82.00
Forecasted Upside37.28% Upside46.75% Upside86.82% Upside35.72% Upside
Get Prestige Consumer Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

PBH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PBH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Prestige Consumer Healthcare Stock vs. The Competition

TypePrestige Consumer HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.71
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside35.82% Upside1,127.09% Upside7.85% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/21/2024DA Davidson
3 of 5 stars
L. Weiser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$65.00 ➝ $93.00+42.46%
5/21/2024Canaccord Genuity Group
1 of 5 stars
 Reiterated RatingBuy ➝ Buy$80.00 ➝ $80.00+21.88%
11/15/2023Royal Bank of Canada
4 of 5 stars
 Lower TargetSector Perform ➝ Sector Perform$110.00 ➝ $103.00+74.58%
11/15/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$124.00 ➝ $117.00+99.12%
6/26/20233M
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingReiterates
2/17/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$72.00 ➝ $71.00+15.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:53 PM ET.

PBH Forecast - Frequently Asked Questions

What is Prestige Consumer Healthcare's forecast for 2024?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Prestige Consumer Healthcare is $98.25, with a high forecast of $117.00 and a low forecast of $80.00.

Should I buy or sell Prestige Consumer Healthcare stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PBH shares.

Does Prestige Consumer Healthcare's stock price have much upside?

According to analysts, Prestige Consumer Healthcare's stock has a predicted upside of 58.03% based on their 12-month stock forecasts.

Has Prestige Consumer Healthcare been upgraded by Wall Street analysts recently?

Over the previous 90 days, Prestige Consumer Healthcare's stock had 1 upgrade by analysts.

What analysts cover Prestige Consumer Healthcare?

Prestige Consumer Healthcare has been rated by research analysts at Canaccord Genuity Group, and DA Davidson in the past 90 days.

Do Wall Street analysts like Prestige Consumer Healthcare more than its competitors?

Analysts like Prestige Consumer Healthcare more than other "medical" companies. The consensus rating score for Prestige Consumer Healthcare is 2.75 while the average consensus rating score for "medical" companies is 2.71. Learn more on how PBH compares to other companies.


This page (NYSE:PBH) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners